Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

STARSOURCE MULTITRADE LIMITED

Healthcare › Pharmaceuticals & Biotechnology
₹108.65
at close · 28 Oct 2026
▼ 6.34 (-5.51%)

Latest filings

Next results: Mon, 2 Nov · Financial Results
  1. Board meeting set for November 2 to approve September quarter results · Results
  2. Compliance certificate for Q2 FY27 dematerialisation under SEBI Reg 74(5) · Compliance
  3. 84th AGM voting results: both resolutions passed with near-unanimous approval · Board & Shareholder Meetings
All filings ↓
Ask Nexa about STARSOURCE MULTITRADE LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹1 Cr over the trailing twelve months.

Market Cap
₹16 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
3.2%·
ROCE (5y median)
ROE 2.6% (5y median) · margin -2254.8%
Leverage
0.00·
Debt / Equity · low
Net cash ₹0.01 Cr
Moves on a normal day
3.49%·
Median daily move
Last 247 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#151/163
ROCE#183/183
ROE#166/166
Debt / Equity#1/166
Profit growth#44/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
No borrowings on the balance sheet
lower than 79% of its 166 Pharmaceuticals peers
Concerns
Erratic profits — up in only 2 of the last 5 years
Returns on capital 3.2% (5-year median)
#183 of 183 in Pharmaceuticals on the latest reported figures · down from 2.8% in FY21

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from STARSOURCE MULTITRADE LIMITED's filed financials and exchange disclosures

What does STARSOURCE MULTITRADE LIMITED do?

STARSOURCE MULTITRADE LIMITED is a Pharmaceuticals & Biotechnology company listed on BSE.

Is STARSOURCE MULTITRADE LIMITED profitable?

No. Over the trailing twelve months STARSOURCE MULTITRADE LIMITED reported a net loss of ₹12 Cr on revenue of ₹0.53 Cr.

Does STARSOURCE MULTITRADE LIMITED pay a dividend?

Not in the latest reported year — STARSOURCE MULTITRADE LIMITED's dividend payout for FY26 was nil.

Is STARSOURCE MULTITRADE LIMITED debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹0.01 Cr of cash.

How much does the STARSOURCE MULTITRADE LIMITED share price move in a day?

On a typical session STARSOURCE MULTITRADE LIMITED moves 3.49% — that is the median absolute close-to-close move across its last 247 trading days. MarketPing measures each filing's price reaction against it.

When are STARSOURCE MULTITRADE LIMITED's next results?

Financial Results on Mon, 2 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track STARSOURCE MULTITRADE LIMITED's announcements?

Every NSE and BSE filing by STARSOURCE MULTITRADE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.